Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07527182) titled 'Artemisinin Partial Resistance in Ethiopian Plasmodium Falciparum: A Multisite Clinical, Molecular and In Vitro Study' on April 7.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Didier Menard
Condition:
Malaria (Plasmodium Falciparum)
Drug Resistance
Artemisinin-resistant
Ethiopia
Intervention:
Drug: Artemether-Lumefantrine Tab 20-120mg
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 1, 2024
Target Sample Size: 277
Countries of Recruitment:
Ethio...